Development Priorities Sample Clauses

Development Priorities. The possibility to propose and participate in collaborative projects for the development of XXXXX applications that are of interest to the Member. - Access to XXXXX documents and courses. In addition to the benefits above, Standard Members shall have: - Two days per Year of training provided by XXXXX Team at special prices. - For specific developments, the Member has access to a list of XXXXX experts (other than staff of XXXXX Team). Note that Inria will give only contact details. It shall not be held responsible for any troubles resulting from the use by the Member of expert’s services. - Its logo posted on most of the XXXXX website pages. All these benefits and offers will be accessible via the XXXXX Consortium Website. The Member will subscribe to all these benefits on XXXXX Consortium Website.
Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
Development Priorities. The detailed plans for community health and care services are set out in the documents listed in the introduction to this report and are not replicated here. Priorities for reviewing commissioning arrangements are as follows: • Meals on Wheels delivery The current arrangements are for the most part the legacy of Compulsory Competitive Tendering arrangements introduced in the 1990s, which resulted in an increase in cost at the time and costs are still high. • 80% increase in long term care for older people by 2025 Development of extra care housing and Telecare services as alternatives to residential care. Implementing the findings of the Dementia Redesign Project and Long Term Care review. • Promoting 3rd sector provision of non-health and care support activities Refocus health and care service provision to meet health and care needs. Purchase a range of social activities and community support in local communities from voluntary and not-for-profit organisations. • Stimulate private sector provision of domestic support services Provide information and advice to local enterprises regarding the demand for assistance with domestic tasks. • Implement Standard SLA Implement a standard SLA format, which supports a negotiated approach when commissioning services from voluntary and not-for- profit organisations. The SLA template will be reviewed periodically to ensure any changes in legislation, policy and guidance are incorporated as appropriate. CHCP Agreement 2010-2013 Section 3 Commissioning 13 Task Lead Responsibility Resource Implications Timescales Comments
Sample 1
Development Priorities. An assessment of development priorities within the project area (Limuru) ranked water high on the list of respondents’ perceived development priorities. Water and sewer comes ahead as a priority amongst 13 development social problems mentioned by the respondents, based on the results of the pair-wise matrix rankings done with 20 community members as shown below in table 3: Table3: Pair-wise Ranking Results Social Problem Score Rank Water 24 1 Schools 15 4 Roads 14 6 Playing Field 0 13 Vocational facilities 8 9 Illicit Brew 2 12 Rehabilitation Facilities 6 10 Child Abuse 15 4
Sample 1
Development Priorities. An assessment of development priorities within Kiambu ranked water high on the list of respondents’ perceived development priorities. Water and sanitation comes ahead as a priority amongst 6 development social problems mentioned by the respondents, based on the results of the pair-wise matrix rankings done with 20 community members as shown in table 3 below Table 3: Pair-wise Ranking Results Social Problem Score Rank Water 10 1 Garbage 2 5 Playing Ground 0 6
Sample 1
Development Priorities. Tresed’s first phase of development shall focus on: Festival venue and site plan. Marketing and Media Plan. Sponsorship plan. Preliminary talent analysis. Tresed’s second phase of development shall focus on implementation of key Phase 1 issues such as soliciting actual sponsors, marketing, media and financial partners, subcontractors for physical production, talent availability, etc.
Sample 1
Development Priorities. The Development Committee shall have the right to include in any Development Plan and Budget activities beyond the scope of the activities set forth in the initial Development Plan and Budget in Exhibit 3.1; provided that activities under each Development Plan and Budget shall extend only to the development of Approved Products expressly set forth therein. Nothing in this Agreement, including Articles 6 and 7 and the diligence obligations in Article 7, shall create or imply any obligation of either Party to include any specific Collaboration Product or Approved Product in the Development Plan and Budget or to approve any proposed Specification to cause a Collaboration Product to become an Approved Product.
Sample 1
Development Priorities. The parties agree that the properties which shall be developed shall be the properties listed as 1-4 above. Simultaneous with renovation of the partially completed shopping center, it is anticipated that the ocean front 9 acres across from the shopping center shall be developed into a suitable condominium and/or hotel project and the Hills of Baja Mar lots built out or sold. PAYMENT OF POINTS & FEES FOR INVESTMENT CAPITAL: The parties agree that when any investment capital IS raised, U.S. West shall be entitled to a 5% fee on all money raised and LAS BRISAS shall, likewise, be entitled to a 5% fee of all money raised, payment of this fee shall be for providing necessary support to the fund raising endeavors of the Joint Venture. These fees shall be paid immediately upon investment funds becoming available.
Sample 1
AutoNDA by SimpleDocs
Development Priorities. NEW TRUSTCO will establish priorities with respect to applications development projects and communicate the same to Chase. Chase will perform applications development projects in accordance with such priorities. In this regard, NEW TRUSTCO may request that Chase propose such priorities for NEW TRUSTCO's approval or modification. NEW TRUSTCO may from time to time adjust priorities previously established. Chase and NEW TRUSTCO will mutually agree to project schedules, priorities and overall resource allocation. Chase will promptly inform NEW TRUSTCO if it determines that NEW TRUSTCO's directions may result in the extension of other project schedules, or may impact the provision of Services, particularly for projects that are critical to NEW TRUSTCO operations or that are required to maintain regulatory compliance. Subject to the foregoing, Chase will remain responsible for timely completion of maintenance and development projects.
Sample 1
Development Priorities. It is the intent of the Parties to develop under the Development Program multiple Collaboration Products and indications of such Collaboration Products within the Field, giving due consideration to the priorities of both Schering and DUSA and to balance those priorities so as to mutually agree upon the priorities of particular Collaboration Products and indications to be collaboratively developed under the Development Program.
Sample 1

Related to Development Priorities

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Development of Products (a) During the term of this Agreement, ViewRay may from time to time seek services from PEKO with respect to the development of certain Products that can be incorporated into the ViewRay Renaissance™ MRI-guided radiation therapy system. For each Program to be undertaken by PEKO pursuant to this Agreement, the parties will prepare a “Work Statement” and agree to said “Work Statement” in substantially the form attached as Attachment 1. Each Work Statement will describe: (i) the (i) services that PEKO will be responsible for providing to ViewRay and the deliverables that PEKO will be responsible for delivering to ViewRay (“Deliverable(s)”), (ii) delivery schedule for the Deliverables, (iii) pricing terms, (iv) work plan for the Program, and (v) ViewRay’s responsibilities in connection with the Program. Each Work Statement will be prepared based upon the requirements and information provided to PEKO by ViewRay. A separate Work Statement will be required for each Program; and each Work Statement will become subject to this Agreement only when mutually agreed and signed by ViewRay and PEKO.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Research Matters By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent’s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.

  • Development Rights The Employee agrees and declares that all proprietary information including but not limited to trade secrets, know-how, patents and other rights in connection therewith developed by or with the contribution of Employee's efforts during his employment with the Company shall be the sole property of the Company. Upon the Company's request (whenever made), Employee shall execute and assign to the Company all the rights in the proprietary information.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development Reports Beginning six months after Effective Date and ending on the date of first commercial sale of a Licensed Product in the United States, LICENSEE shall report to Cornell progress covering LICENSEE's (and Affiliate's and Sublicensee's) activities and efforts in the development of rights granted to LICENSEE under this Agreement for the preceding six months. The report shall include, but not be limited to, activities and efforts to develop and test all Licensed Products and obtain governmental approvals necessary for marketing the same. Such semi-annual reports shall be due within sixty days (60) of the reporting period and shall use the form as provided herein as Appendix C.

  • Commercialization Plans As soon as practicable after formation of the JCC (following Acucela’s exercise of an Opt-In Right under Section 3.1), the JCC shall prepare and approve the initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation (and, if applicable, any New Formulation or Other Indication Product) in the Territory. The Parties shall use Commercially Reasonable Efforts to ensure that such initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation is consistent with the general Commercialization Plan outline set forth in Exhibit C attached hereto and incorporated herein (the “General Commercialization Plan Outline”). The JCC shall prepare and approve a separate Commercialization Plan for Commercialization of Licensed Product for the Initial Indication in the Initial Formulation in the Territory and for Commercialization of each Other Indication Product and New Formulation (if any) in the Territory, and shall update and amend each Commercialization Plan not less than annually or more frequently as needed to take into account changed circumstances or completion, commencement or cessation of Commercialization activities not contemplated by the then-current Commercialization Plan. Amendments and revisions to the Commercialization Plan shall be reviewed and discussed, in advance, by the JCC, and Otsuka agrees to consider proposals and suggestions made by Acucela regarding amendments and revisions to the Commercialization Plan. Any amendment or revision to the Commercialization Plan that provides for an increase or decrease in the number of FTEs for any Phase 3b Clinical Trials or Post-Approval Studies as compared to the previous version of the Commercialization Plan, or that provides for addition or discontinuation of tasks or activities as compared to the previous version of the Commercialization Plan, or that moves forward the timetable for activities reflected in the Commercialization Plan, shall provide for a reasonable ramp-up or wind-down period, as applicable, to accommodate a smooth and orderly transition of Commercialization activities to the amended or revised Commercialization Plan. Each Commercialization Plan shall identify the goals of Commercialization contemplated thereunder and shall address Commercialization (including Co-Promotion) activities related to the Licensed Product (including, if applicable, any Other Indication Product), including:

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

Time is Money Join Law Insider Premium to draft better contracts faster.